FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) announced its senior executive management will be attending the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023, in San Francisco, California. Dr. Lakshmi P. Kotra, Director at FSD Pharma and CEO of the Company’s wholly owned subsidiary Lucid Psycheceuticals, and Zeeshan Saeed, Founder and President of FSD Pharma, will be in attendance and available for in-person meetings throughout the conference.
Lucky Minerals (TSX-V:LKY, OTC:LKMNF) told investors it will participate this month in Renmark Financial Communications Inc.'s live Virtual Non-Deal Roadshow Series to discuss the latest company update and investor presentation. The presentations will feature president and CEO François Perron and will be followed by a live Q&A. Investors interested in participating in these events will need to register using the links below. The company said registration for the live event may be limited but access to the replay after the event will be on the company's website.